Trial intelligence / Profile preview

In vivo measurement of cefuroxime in subcutaneous and bone tissue using microdialysis

2013-001138-17Phase 4Completed

Sponsor
Orthopedic Research Unit, Aarhus University Hospital
Start
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of cefuroxime in surgical site infection (SSI) and Staphylococcosis (2 arms), sponsored by Orthopedic Research Unit, Aarhus University Hospital. Primary endpoint: Time above MIC for Staphylococcus aureus. Started Jul 2013; status: completed.

02

Drugs

cefuroxime
03

Conditions

surgical site infection (SSI)Staphylococcosis

Beyond the preview

Go deeper on 2013-001138-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001138-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call